CLINICAL_TRIALS
trial_result
· 2024-12-12
Clinical Trial Update: Study of Jaktinib Hydrochloride Tablets in Participants With Idiopathic Pulmonary Fibrosis [Phase 2]
Summary
Phase 2 clinical trial evaluating jaktinib hydrochloride tablets in idiopathic pulmonary fibrosis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd | Conditions: Idiopathic Pulmonary Fibrosis | Phase 2 | Status: COMPLETED